Bibliometrics and visualization analysis of transplant pharmacy based on Web of Science database

doi:10.3877/cma.j.issn.1674-3903.2025.05.012

Abstract

Abstract:

Objective

Bibliometric and visualization analyses of the literature in the field of transplant pharmacy were conducted to inform the development of transplant pharmacist teams, advance transplant pharmacy research, and enhance transplant pharmacy service standards in China.

Methods

Publications related to transplantation and pharmacy were searched in the Web of Science Core Collection database from the establishment of the database to December 2024. Bibliometric method was used to analyze the annual publication output, citation frequency, as well as the countries, authors, and institutions. CiteSpace software and VOSviewer were used to detect bursts and clusters of keywords and citations, in order to analyze the current status and hotspots of the field.

Results

A total of 3 168 articles were included in this study, with the earliest publication dating back to 1992. The highest number of publications occurred in 2022 (n=273). The total number of citations was 66, 740, with the highest figure in 2024 reaching 6 116. The United States had the most publications (n=1 659) and maintained the strongest collaborations with other countries. A total of 3 077 institutions participated in the publications, with the Pennsylvania Commonwealth System of Higher Education (n=176) ranking first in publication volume. A total of 16 408 authors contributed to the publications, with Taber DJ (n=78) being the most prolific author. The top ten most intense emergent citations sustained their pre-eminence for a period of 3 to 4 years. The most significant emergent citation was "Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report" by Spanish scholar Brunet M in 2019, with a citation intensity of 37.78. Sixty keywords were subjected to cluster analysis, forming three distinct clusters. These clusters focus on three key areas: assessment of therapeutic efficacy in organ transplantation, immunotherapy in organ transplantation, and the pharmacokinetics and genomics of immunosuppressive agents.

Conclusions

By visualizing and analyzing the research in the field of transplant pharmacy, this study provides guidance for the further development of transplant pharmacy, the improvement of pharmacy services, and the conduct of related research in China in the future.

Key words: Transplant pharmacy, Pharmacy service, Bibliometrics, Visualization analysis

Xinge Lv, Ying Zhang, Xiaozhu Zhou, Zhenhuan Wang, Xiangli Cui. Bibliometrics and visualization analysis of transplant pharmacy based on Web of Science database[J]. Chinese Journal of Transplantation(Electronic Edition), 2025, 19(05): 362-367.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhyzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3903.2025.05.012

https://zhyzzz.cma-cmc.com.cn/EN/Y2025/V19/I05/362

Figures/Tables 6

References 25

1	张建萍，李聪，魏玉辉，等. 美国器官移植临床药学服务内容和模式简介[J]. 中国现代应用药学，2021，38(4)：481-485.
2	刘冉佳，张志琪，黄文华，等. 肝移植儿童生命质量评估量表的系统综述[J]. 药物流行病学杂志，2022，31(4)：264-270.
3	Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases[J]. AMIA Annu Symp Proc, 2005：724-728.
4	van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping[J]. Scientometrics, 2010，84(2)：523-538.
5	Stratta RJ, Shaefer MS, Cushing KA, et al. A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy[J]. Arch Surg, 1992，127(1)：55-63.
6	Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium[J]. Clin Infect Dis, 2020，71(6)：1367-1376.
7	Brunet M, van Gelder T, Åsberg A, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report[J]. Ther Drug Monit, 2019，41(3)：261-307.
8	Birdwell KA, Decker B, Barbarino JM, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing[J]. Clin Pharmacol Ther, 2015，98(1)：19-24.
9	Kotton CN, Kumar D, Caliendo AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation[J]. Transplantation, 2018，102(6)：900-931.
10	Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019，33(9)：e13512.
11	Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference[J]. Ther Drug Monit, 2009，31(2)：139-152.
12	Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I[J]. Clin Pharmacokinet, 2010，49(3)：141-175.
13	Shuker N, Bouamar R, van Schaik RH, et al. A randomized controlled trial comparing the efficacy of Cyp3a5 genotype-based with body-weight-based tacrolimus dosing after living donor kidney transplantation[J]. Am J Transplant, 2016，16(7)：2085-2096.
14	Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients[J]. Am J Transplant, 2004，4(4)：611-620.
15	Hesselink DA, Bouamar R, Elens L, et al. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation[J]. Clin Pharmacokinet, 2014，53(2)：123-139.
16	Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients[J]. Clin Pharmacokinet, 2007，46(1)：13-58.
17	国家卫生健康委员会. 全国医疗服务项目技术规范(2023年版)[EB/OL]. (2023-09-28)[2024-9-11]. URL
18	国家卫生健康委员会办公厅. 关于开展驻科药师工作模式试点的通知[EB/OL]．(2024-01-08)[2024-09-11]. URL
19	Alloway RR, Dupuis R, Gabardi S, et al. Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team[J]. Am J Transplant. 2011，11(8)：1576-1583.
20	Chandran MM, Cohen E, Doligalski CT, et al. The measure of impact: proposal of quality metrics for solid organ transplant pharmacy practice[J]. Am J Transplant, 2024，24(2)：164-176.
21	陈文倩，张雷，张弋，等. 实体器官移植他克莫司个体化治疗专家共识[J]. 中国医院用药评价与分析，2021，21(12)：1409-1424.
22	闫美玲，刘立玮，张弋. 药物基因组学与免疫抑制剂的个体化用药[J/OL]. 实用器官移植电子杂志，2017，5(1)：72-76.
23	Li J, Li Z. Differences and similarities in clinical pharmacy practice in China and the United States: a narrative review[J]. Eur J Hosp Pharm, 2018，25(1)：2-5.
24	马葵芬，朱硕，宋文彬，等. 移植药学门诊的建立及运行效果分析[J]. 今日药学，2018，28(12)：824-828.
25	Yin Z, Zhang W, Jia X, et al. " Access to pharmacy services is difficult in China" ：a qualitative study from the perspective of transplant recipients to explore their expectations[J]. BMC Health Serv Res, 2024，24(1)：387.

国家	发文量[篇(%)]	总被引频次	平均被引频次(次/篇)
美国	1 659(52.4)	41 787	25.19
中国	271(8.6)	2 768	10.21
法国	219(6.9)	8 449	38.58
荷兰	208(6.6)	9 806	47.14
加拿大	190(6.0)	6 245	32.87
日本	176(5.6)	3 913	22.23
澳大利亚	141(4.4)	5 565	39.47
西班牙	127(4.0)	5 812	45.76
英国	104(3.3)	7 246	69.67
罗马尼亚	98(3.1)	2 350	23.98

国家	发文量[篇(%)]	总被引频次	平均被引频次(次/篇)
美国	1 659(52.4)	41 787	25.19
中国	271(8.6)	2 768	10.21
法国	219(6.9)	8 449	38.58
荷兰	208(6.6)	9 806	47.14
加拿大	190(6.0)	6 245	32.87
日本	176(5.6)	3 913	22.23
澳大利亚	141(4.4)	5 565	39.47
西班牙	127(4.0)	5 812	45.76
英国	104(3.3)	7 246	69.67
罗马尼亚	98(3.1)	2 350	23.98

机构	国家	发文量[篇(%)]	总被引频次	平均被引频次(次/篇)
Pennsylvania Commonwealth System of Higher Education	美国	176(5.6)	7 997	45.44
University of Pittsburgh	美国	151(4.8)	6 922	45.84
Institut National de la Sante et de la Recherche Medicale Inserm	法国	116(3.7)	4 257	36.70
Medical University of South California	美国	110(3.5)	1 414	12.85
University of California System	美国	109(3.4)	5 735	52.61
Assistance Publique Hopitaux Paris Aphp	法国	105(3.3)	5 216	49.68
University System of Ohio	美国	100(3.2)	3 011	30.11
Erasmus University Rotterdam	荷兰	99(3.2)	4 722	47.70
US Department of Veterans Affairs	美国	95(3.0)	4 658	49.03
Veterans Health Administration	美国	95(3.0)	4 658	49.03

机构	国家	发文量[篇(%)]	总被引频次	平均被引频次(次/篇)
Pennsylvania Commonwealth System of Higher Education	美国	176(5.6)	7 997	45.44
University of Pittsburgh	美国	151(4.8)	6 922	45.84
Institut National de la Sante et de la Recherche Medicale Inserm	法国	116(3.7)	4 257	36.70
Medical University of South California	美国	110(3.5)	1 414	12.85
University of California System	美国	109(3.4)	5 735	52.61
Assistance Publique Hopitaux Paris Aphp	法国	105(3.3)	5 216	49.68
University System of Ohio	美国	100(3.2)	3 011	30.11
Erasmus University Rotterdam	荷兰	99(3.2)	4 722	47.70
US Department of Veterans Affairs	美国	95(3.0)	4 658	49.03
Veterans Health Administration	美国	95(3.0)	4 658	49.03

作者	机构	国家	发文量[篇(%)]	总被引频次	平均被引频次(次/篇)
Taber DJ	Medical University of South Carolina	美国	78(2.5)	992	12.72
Van Gelder T	Erasmus University Rotterdam	荷兰	58(1.8)	3 743	64.53
Hesselink DA	Erasmus University Rotterdam	荷兰	55(1.7)	2 971	54.02
Asberg A	University of Oslo School of Pharmacy	挪威	51(1.6)	2 610	51.18
Baliga PK	Medical University of South Carolina	美国	41(1.3)	747	18.22
Vwnkataramanan R	University of Pittsburgh	美国	41(1.3)	1 209	29.49
Hartmann A	University of Oslo	挪威	40(1.3)	1 428	35.70
Jorgenson MR	University of Wisconsin System	美国	40(1.3)	316	7.90
Chavin KD	Medical University of South Carolina	美国	36(1.1)	605	16.81
Staatz CE	University of Queensland	澳大利亚	35(1.1)	935	26.71

Please choose a citation manager

Content to export